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Objective: We sought to report our experience with combined retrograde visceral revascularization and endovas-
cular exclusion (hybrid procedure) of thoracoabdominal aortic aneurysms.
Methods: From February 2005 to October 2007, the prospectively collected data of 18 consecutive patients un-
dergoing hybrid repair were analyzed. Median age was 73 years; Crawford–Safi extent included 2 type I, 8 type II,
7 type III, and 1 type V thoracoabdominal aortic aneurysms; 13 were atherosclerotic and 5 were postdissecting
aneurysms. Previous open or endovascular aortic surgery had been performed in 11 (61.1%) patients. Society for
Vascular Surgery/North American Chapter of the International Society for Cardiovascular Surgery preoperative
risk stratification identified mild-to-severe hypertension and pulmonary and cardiac status in 88.9%, 67.7%, and
88.9% of the patients, respectively.
Results: Fifty-four visceral vessels were bypassed in 18 patients. As an adequate inflow site, the common iliac
artery was identified in 15 (83.3%) patients, the infrarenal native aorta was identified in 1 (5.6%) patient, and a pre-
vious tube graft was identified in 2 (11.1%) patients. Median operating time was 360 minutes (range, 210–600
minutes), and median blood loss was 3200 mL (range, 1000–18,000 mL). Aneurysm exclusion was achieved in
17 patients. Thirty-day mortality was 16.7% (n¼ 3/18). Complications included paraplegia (n¼ 1) and acute myo-
cardial infarction (n ¼ 2). Median follow-up was 23 months (range, 8–42 months), with visceral graft patency at
follow-up or death of 98.1% (n ¼ 53/54). One early and 1 late type Ia endoleak (11.8%, n ¼ 2/17), no type III
endoleaks, and 5 type II endoleaks were detected, none necessitating adjuvant procedures.
Conclusion: The visceral hybrid repair is a feasible and relatively safe procedure for extensive thoracoabdominal
aortic aneurysms. Even considering the significantly high mortality and morbidity rates, it might represent a viable
alternative in a cohort of patients historically deemed at high risk for traditional surgical intervention. (J Thorac
Cardiovasc Surg 2009;138:1331-8)
Biasi et al Acquired Cardiovascular DiseaseAneurysm resection and prosthetic graft replacement have
formed the mainstay of surgical treatment for thoracoabdo-
minal aortic aneurysms (TAAAs). With this technique,
patient mortality is related to the period of aortic occlusion,
operative blood loss, extent of the aneurysm, and patient co-
morbidity.1 Most units use adjunctive strategies, such as left
heart bypass, selective perfusion, and the routine drainage of
cerebrospinal fluid (CSF), to improve outcomes.2,3 In spite
of these adjunctive techniques, many patients with signifi-
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because of a high predicted perioperative mortality.
The mortality and morbidity rates after conventional re-
pair of TAAAs are still significant, with specialized centers
reporting mortality rates of 5% to 16% and paraplegia rates
of 4% to 11%.4-7 However, these excellent results are not
representative of outcomes outside of these centers, with na-
tional/community mortality rates exceeding 20% at 30 days
and 30% at 1 year.8
The application of combining surgical and endovascular
strategies in the management of complex aortic disease has
been suggested to reduce the surgical insult by obviating
the need for thoracotomy and aortic crossclamping while
also reducing the duration of visceral and renal ischemia.
The exclusion of TAAAs by means of an endoluminal stent
graft delivered through a remote arteriotomy or conduit re-
quires sufficient length of proximal and distal landing zones
(DLZs) in nondiseased or replaced aortas and is also re-
quired to safeguard perfusion of the gut and kidneys.
A hybrid repair can be defined as a combined surgical and
endovascular approach in which transperitoneal retrogradeardiovascular Surgery c Volume 138, Number 6 1331
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DAbbreviations and Acronyms
ASA ¼ American Society of Anesthesiologists
CSF ¼ cerebrospinal fluid
DLZ ¼ distal landing zone
PLZ ¼ proximal landing zone
SMA ¼ superior mesenteric artery
TAAA ¼ thoracoabdominal aortic aneurysm
visceral revascularization is used to create an adequate DLZ
for endovascular TAAA endograft exclusion. The retrograde
visceral bypass maintains perfusion to the visceral and renal
arteries. This approach can be combined with great vessel
transposition or bypass to create an adequate proximal at-
tachment site for the thoracoabdominal endograft.
Initial enthusiastic reports from small case series have
reported that the hybrid repair of TAAAs is feasible, even
in high-risk patients, and that successful aneurysm exclusion
can be achieved in the majority of patients, with satisfactory
patient outcomes.9 The incidence of visceral bypass graft oc-
clusions and sustained type I endoleaks and the durability of
endograft design have not yet been completely defined in the
literature.10 We report our preliminary experience with a co-
hort of 18 consecutive patients.
MATERIALS AND METHODS
Patients
From February 2005 to October 2007, the prospectively collected hospi-
tal records of 18 consecutive patients who had undergone combined visceral
revascularization and endovascular stenting of complex TAAAs were ana-
lyzed (Figures 1 and 2).
Primary preoperative diagnostic imaging was obtained in all patients by
means of 64-slice computed tomographic scanning of the thorax, abdomen,
and pelvis. All patients were assessed for evidence of concomitant carotid ar-
tery disease with preoperative duplex scanning, and cardiac evaluation used
dobutamine stress echocardiography. In 5 patients radionucleotide excretion
renography (mercapto-acetyltriglycine) was necessary to evaluate dynamic
renal function and dominance before proceeding to renal revascularization.
TAAAs were classified according to the revised Crawford–Safi TAAA
extent classification into types II (n ¼ 8), III (n ¼ 7), I (n ¼ 2), and V
(n¼ 1). The study group comprised 10 (55.6%) men and 8 (44.4%) women
with a median age of 73 years (range, 50–79 years).
Eleven (61.1%) patients had undergone previous aortic operations (13
procedures). Seven of these patients had a history of either open or
endovascular abdominal aortic aneurysm repair (2 patients for ruptured
infrarenal aneurysm), and 6 patients had undergone earlier TAAA repair (1 pa-
tient with aortic root replacement, a further patient having had a total intratho-
racic aortic arch debranching in addition to aortic root and valve replacement,
and 3 patients undergoing thoracic endovascular aneurysm repair).
The median maximum aneurysm diameter was 65 mm (range, 45–96
mm), with the majority of aneurysms being atherosclerotic in cause (n ¼
13, 72.2%). The remaining 5 patients had previous chronic aortic dissec-
tions with aneurysmal degeneration, of which 2 occurred in patients with
underlying Marfan syndrome.
The median maximum diameter of chronic dissecting aneurysms was 64
mm (range, 58–85 mm). The distance between the intimal tear and the left
subclavian artery was less than 10 mm in 2 patients requiring supra-aortic
vessel bypass. The chronic dissection involved the celiac trunk and superior1332 The Journal of Thoracic and Cardiovascular Sumesenteric artery (SMA) in 3 patients and all 4 visceral vessels in a further 2
patients. In relation to our previous experience, the indication for treatment
was sac enlargement in chronic postdissecting aneurysms involving the vis-
ceral patch, evidence of distal fenestrations, or both.11
Individual patient risk factors and comorbidities were recorded accord-
ing to the Society for Vascular Surgery/North American Chapter of the
International Society for Cardiovascular Surgery (Table 1). All patients un-
dergoing elective and urgent operations had been preoperatively classified
as American Society of Anesthesiologists (ASA) class 3 or 4 on the basis
FIGURE 1. Intraoperative 3-vessel debranching. An inverted, bifurcated,
16- 3 8–mm, silver-bonded Dacron graft fashioned end-to-side to the left
common iliac artery (CIA) bypassing to the celiac trunk (a) and superior
mesenteric artery (b) is shown. The left renal artery (c) is revascularized
with a separate 6-mm Dacron graft by using an end-to-end distal anastomo-
sis and an end-to-side proximal anastomosis to one limb of the inflow graft.rgery c December 2009
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emergency operations were classified as ASA class 5.
Elective repairs were undertaken in 14 (77.8%) patients. Two (11.1%)
patients required urgent procedures for symptomatic TAAAs, and a further
2 (11.1%) patients were treated on an emergency basis for radiologically
proved aneurysm rupture in the presence of hemodynamic instability (1 tho-
racic and 1 abdominal rupture).
Hybrid Procedure: Surgical Technique and
Considerations
Five (27.8%) patients in this series were treated within a single hospital
admission with simultaneous surgical and endovascular procedures, with
endograft deployment proceeding immediately after visceral vessel de-
branching in the operating suite. The remaining patients (n¼ 13) underwent
staged exclusion of the aortic aneurysm.
The median duration between initial visceral revascularization and final
endovascular exclusion of the TAAA was 112 days (range, 49–240 days).
FIGURE 2. Postoperative computed tomographic angiograph (3-dimen-
sional rendering) of a completed hybrid. Four-vessel visceral debranching
(inverted, bifurcated, 16-3 8–mm Dacron graft from the left common iliac
artery to the celiac trunk and superior mesenteric artery and separate 6-mm
Dacron grafts from each limb of the inflow graft to the left and right renal
arteries) with thoracoabdominal aortic aneurysm endovascular exclusion
(Medtronic Valiant endografts) is shown.The Journal of Thoracic and CThe median delay between stage I and II was prolonged by 5 outliers
(>120 days): 3 patients who required custom-made endografts, 1 who re-
quired coronary revascularization, and 1 with chronic obstructive pulmo-
nary disease who underwent pulmonary rehabilitation in between stages.
No patient died from aneurysm-related rupture in this period, but 1 pa-
tient died in the early postoperative period, precluding subsequent endovas-
cular repair, as a result of embolic left colonic infarction and subsequent
multiorgan failure on the third postoperative day.
Visceral Debranching
Surgical intervention was performed after achievement of general and
epidural anesthesia with the patient lying supine. A midline transperitoneal
incision was preferentially used to gain access to the visceral, renal, and in-
flow vessels. Inflow for retrograde revascularization was evaluated in each
patient on the basis of preoperative imaging and confirmed with intraoper-
ative findings. Preferentially, inflow was obtained from the right common
iliac artery in most patients by means of an inverted, 163 8–mm, silver-im-
pregnated, rifampicin-bonded Dacron graft fashioned end-to-side to the
common iliac artery (n¼ 15). Where the aorta had been previously repaired
with a graft (previous abdominal aortic aneurysm open repair in 2 patients),
an end-to-side anastomosis was fashioned to the distal aspect of the graft,
allowing for a sufficient DLZ at subsequent endograft deployment. The na-
tive infrarenal aorta was used in 1 patient who had a type V TAAA with an
uninvolved infrarenal abdominal aorta. In 1 female patient with small native
common iliac arteries and a type I TAAA, right and left common iliac
arteries were used individually for inflow sources for the celiac trunk and
SMA, respectively.
End-to-side anastomosis from the limb of the inflow graft to the SMA
was fashioned with a lazy C configuration. The other limb of the bifurcated
inflow graft was anastomosed to a branch of the celiac axis by using a tu-
nneled retropancreatic approach. Each individual renal artery, where indi-
cated, was revascularized with a separate 6-mm Dacron graft by using an
end-to-end anastomosis with an end-to-side proximal anastomosis to each
limb of the inflow graft. The celiac trunk and SMA were subsequently dou-
ble ligated at their origin with nonabsorbable sutures and metal clips, and the
peritoneum or omentum was used to cover any exposed graft material.
In 4 cases a further 10-mm Dacron prosthetic conduit was fashioned end-
to-side to either the aortic graft (n ¼ 1) or iliac graft (n ¼ 3) to anastomose
distally to the common femoral artery (n ¼ 2) or the superficial femoral ar-
tery (n ¼ 2) to overcome severe anatomic limitations of native access ves-
sels, which might have hindered subsequent endovascular stent delivery.
RESULTS
A total of 54 visceral vessels were bypassed in 18 patients
(Table 2). Eight (44.4%) patients underwent a complete ret-
rograde, 4-vessel, debranching revascularization, and in the
TABLE 1. Patient risk factor grading system for cardiovascular risk
factors and comorbidity tabulated according to the Society for
Vascular Surgery/North American Chapter of the International
Society for Cardiovascular Surgery (n ¼ 18)
Risk factor None (%) Mild (%) Moderate (%) Severe (%)
Diabetes mellitus 15 (83.3) 2 (11.1) 1 (5.6) 0
Tobacco use 3 (16.7) 5 (27.8) 6 (33.3) 4 (22.2)
Hypertension 3 (16.7) 8 (44.4) 4 (22.2) 3 (16.7)
Hyperlipidemia 4 (22.2) 5 (27.8) 3 (16.7) 6 (33.3)
Cardiac status 11 (61.1) 4 (22.2) 2 (11.1) 1 (5.6)
Carotid status 12 (66.7) 3 (16.7) 3 (16.7) 0
Renal status 15 (83.3) 3 (16.7) 0 0
Pulmonary status 6 (33.3) 6 (33.3) 5 (27.8) 1 (5.6)ardiovascular Surgery c Volume 138, Number 6 1333
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Patient no. Inflow
Details of visceral
debranching PLZ(mm) DLZ(mm)
Manufacturer of
endograft
Adjunctive surgical
or endovascular procedures
1 Right CIA SMAþcommon
hepatic arteryþ right renal
3 (30) 0 (26) Zenith Cook (branched) Proximal cuff
2 Right CIA SMAþcommon
hepatic artery
3 (30) 2 (26) Valiant
3* Left CIA SMAþsplenic artery 4 (38) 2 (32) Zenith Proximal cuff
4 Left CIA SMAþcommon
hepatic arteryþ right
renalþ left
renalþgraft–SFA
5* Infrarenal aorta SMAþcommon
hepatic arteryþgraft–SFA
4 (40) 2 (34) Valiant Talent
6 Right CIA SMAþcommon
hepatic arteryþ right renal
3 (38) 0 (27) Valiant Zenith
Cook (fenestrated)
7 Right and left CIA SMAþcommon
hepatic artery
3 (28) 2 (26) Valiant
8* Right CIA SMAþcommon
hepatic artery
1 (34) 2 (30) Valiant Carotid–carotid to subclavian
bypass renal stent,
iliac stent
9* Right CIA SMAþcommon
hepatic arteryþ right
renalþ left renal
3 (30) 0 (28) Valiant Talent
10* Right CIA SMAþ left
gastric arteryþ right
renalþ left renal
2 (34) 0 (28) Valiant Carotid subclavian bypass
11 Infrarenal aortic graft SMAþgraft–right CFA 3 (32) 2 (26) Valiant
12 Right CIA SMAþcommon
hepatic artery
3 (38) 0 (28) Valiant Zenith
Cook (fenestrated)
2 cuffs, Palmaz stent
13 Infrarenal aortic graft SMAþcommon
hepatic arteryþ right
renalþ left
renalþgraft–CFA
3 (32) 0 (24) Valiant
14 Right CIA SMAþ right
renalþ left renal
3 (38) 0 (24) Valiant
15 Right CIA SMAþcommon
hepatic arteryþ right
renalþ left renal
3 (38) 0 (24) Valiant
16 Left CIA SMAþcommon
hepatic arteryþ right
renalþ left renal
2 (36) 0 (23) Valiant Talent Carotid subclavian bypass
17 Left CIA SMAþcommon
hepatic arteryþ right
renalþ left renal
3 (32) 0 (20) Valiant
18 Right CIA SMAþcommon
hepatic arteryþ right
renalþ left renal
2 (34) 0 (24) Valiant Carotid subclavian bypass
Patient number 4 died before stage II. PLZ, Proximal landing zone; DLZ, distal landing zone; CIA, common iliac artery; SMA, superior mesenteric artery; SFA, superficial femoral
artery; CFA, common femoral artery. *Postdissecting aneurysm.majority of cases (n¼ 16, 88.9%), both the celiac trunk and
SMA were revascularized. The only 2 exceptions were an
asymptomatic chronic occlusion of the celiac trunk identi-
fied preoperatively and a celiac trunk that could not be ade-
quately exposed because of densely adherent scar tissue in
a patient who had previous hepatic surgery. The celiac trunk1334 The Journal of Thoracic and Cardiovascular Swas revascularized to the common hepatic artery in the ma-
jority of instances (n ¼ 14) and on 1 occasion each to the
splenic artery (n ¼ 1) and the left gastric artery (n ¼ 1).
Four renal arteries in 3 patients were not bypassed because
of scarring or the hemodynamic instability of the patient, re-
quiring ensuing revascularization with custom-madeurgery c December 2009
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sion for endovascular exclusion of the aneurysm.
Hybrid procedures in 3 patients with hourglass-shaped
aneurysms allowed for preservation of renal ostia without
the need for revascularization.
The median operative time for retrograde revascularization
was 360 minutes (range, 210–600 minutes), with a median
estimated blood loss of 3200 mL (range, 1000–18,000 mL).
Three patients in this series required intraoperative sple-
nectomy for inadvertent injury to this organ during surgical
intervention. No other major intraoperative complications
were recorded. Median stay within the intensive care unit
was 3 days (range, 1–14 days).
Endovascular Procedure
Common femoral artery access for the endovascular re-
pair was achieved controlateral to the site of retrograde in-
flow. This negated the risk of iatrogenic trauma or intimal
dissection to the vessels during endograft insertion. Routine
perioperative CSF drainage was not performed in this series
of patients. Patients were woken immediately after the endo-
vascular repair to assess neurologic function, and any patient
with potential spinal cord ischemia had a spinal drain placed.
In the latter part of the series, any patient undergoing left
subclavian artery coverage had a carotid–subclavian artery
bypass.
The extent of thoracoabdominal endografting was defined
according to Ishimaru’s mapping of thoracic aorta (proximal
landing zone [PLZ], 0–4) and Chiesa’s mapping of the ab-
dominal aorta (DLZ, 4–0; Table 2).12,13 The most com-
monly used endograft stents were the Valiant, Talent
(Medtronic, Santa Rosa, Calif), and Zenith (Cook, Bloo-
mington, Ind). In addition, 2 custom-made renal-fenestrated
and 1 branched Cook endograft (Cook, Brisbane, Australia)
were used in the attempt to revascularize 4 renal arteries in
3 patients.
The median proximal neck diameter was 34 mm (range,
28–40 mm), and the median distal neck diameter was 28 mm
(range, 26–34 mm) at DLZ 2 and 24 mm (range, 20–28 mm)
at DLZ 0.
The distal neck was deemed hostile in 4 patients, with
endoluminal thrombus of greater than 50% in 11.1% (n ¼
2/18) and wall calcifications of greater than 40% in 16.7%
(n ¼ 3/18). The remaining 6 patients presented with
a more favorable neck morphology. The presence of adverse
aortic morphology in the distal neck was not associated with
a need for early reintervention for type 1b endoleaks in this
series.14
Endograft diameters and lengths were selected to allow
a 10% to 20% oversizing requirement (depending on the
cause and anatomic characteristics) and stent overlap of at
least 3 cm. PLZs in Safi–Crawford type III, IV, and V aneu-
rysms used all available descending thoracic aortas up to the
left subclavian artery origin. In type I and II TAAAs, theThe Journal of Thoracic and CaPLZ was mandated by aneurysm morphology and the need
for supra-aortic trunk transposition.
Technical success, as defined by aneurysm exclusion
without intraprocedural evidence of type 1 or type 3 endo-
leaks, was achieved in 16 patients. In 1 patient on-table an-
giographic analysis showed the presence of a type 1a
endoleak from the PLZ,2 which, despite a Valiant proximal
extension cuff, could not be fully corrected. Myocardial
ischemia in this patient prevented placement of further prox-
imal endografts.
Mortality
The overall 30-day mortality in this patient cohort was
16.7% (n ¼ 3/18), irrespective of elective, urgent, or emer-
gency presentation. One of these deaths occurred after vis-
ceral debranching (attributed to embolic intestinal
infarction and subsequent multiple organ failure), and there-
fore the endovascular repair was not performed.
Of those patients who had undergone complete aneurysm
exclusion, 1 died as a result of aspiration pneumonia on day
6 after simultaneous repair of a postdissection type II
TAAA, and a further patient died after a middle cerebral
artery stroke following a staged visceral and supra-aortic
trunk debranching and subsequent endovascular exclusion
of a postdissection type II TAAA. Cumulative mortality at
last follow-up was 22.2% (n ¼ 4/18): only 1 patient died
postoperatively (on day 65) after a severe acute myocardial
infarction.
Morbidity
One patient in this series had delayed lower limb paraple-
gia after repair of a type II TAAA. Signs of motor and
sensory loss at the level of T-10 occurred 4 days after
completion of a staged hybrid repair, and this did not im-
prove in spite of CSF drainage. At the latest clinical fol-
low-up (34 months), the patient demonstrated partial
neurologic improvement.
Other complications after visceral revascularization
included acute myocardial infarction in 2 patients with
pre-existing coronary heart disease. In 1 patient this was
identified intraoperatively, and the patient subsequently
underwent coronary artery bypass grafting before a staged
endovascular repair. The other patient presented on an emer-
gency basis with a ruptured TAAA and did not require fur-
ther coronary revascularization.
Two kidneys in 2 patients, who were deemed suitable for
custom-made fenestrated or branched endografts, were sac-
rificed as a result of an inability to place a covered stent in the
target renal vessel. This did not have any determinable effect
on renal function in these patients.
No patients required positive-pressure ventilatory assis-
tance or intubation for longer than 7 days, but postoperative
infective respiratory complications occurred in 2 patients.rdiovascular Surgery c Volume 138, Number 6 1335
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(n ¼ 4/18).15 Three of these patients died. Overall, 55.6%
(n ¼ 10/18) of the patients did not have any perioperative
complications at last follow-up.
Hospital Stay
Median length of stay after visceral and renal revascular-
ization was 18 days (range, 5–42 days). Subsequent admis-
sions for endovascular stenting required a further median
length of stay of 7 days (range, 3–13). Patients treated within
a single hospital admission were discharged at a median of
15 days (range, 9–19 days).
Follow-up
All surviving patients were discharged from the hospital
with a clinic review at 6 weeks. Subsequent follow-up and
surveillance imaging as per protocol with both computed to-
mographic and Duplex scan surveillance were scheduled at
1, 6, and 12 months and annually thereafter.
At death or a median follow-up of 23 months (range, 8–42
months), all but 1 (53/54) of the visceral grafts remained pat-
ent (98.1% patency rate). Postmortem examination in all 3
deceased patients did not reveal graft thrombosis.
One celiac artery graft anastomosed to the common
hepatic artery occluded in the time interval between vis-
ceral revascularization and endograft insertion but was
not associated with symptoms of acute or chronic intestinal
ischemia.
Endoleaks
The cumulative incidence of type I endoleak was 11.8%
(n ¼ 2/17). One required an adjunctive carotid–carotid by-
pass and proximal endograft extension after detection of
a late type 1a endoleak at 14 month’s follow-up. The second
patient had a type 1a endoleak detected intraoperatively that
was not corrected despite the use of a Valiant Freeflo
proximal component (Medtronic). Intraoperative myocar-
dial ischemia prevented further intraoperative attempts at
correction.
No type III endoleaks were seen. Five type II endoleaks,
which did not necessitate further endovascular intervention,
were identified. Of these, 2 resolved spontaneously at 13 and
7 months after exclusion, respectively, with the remaining
patients not demonstrating any sac enlargement on subse-
quent radiologic surveillance.
DISCUSSION
Traditional surgical repair of extensive TAAAs carries an
attendant risk of significant morbidity and mortality and
precludes certain patients from undergoing open repair.
Identifiable patient risk factors predicting adverse outcomes
include emergency presentation, previous aortic replace-
ment, diabetes, smoking history, renal and cardiorespiratory1336 The Journal of Thoracic and Cardiovascular Simpairment, age greater than 79 years, acute dissection, and
the extent of the TAAA.
Published series suggest a 30-day mortality rate approach-
ing 50% in patients stratified as being at highest risk,
thereby precluding their consideration for traditional surgi-
cal intervention.16
The hybrid technique of retrograde visceral revasculariza-
tion followed by endoluminal exclusion of TAAAs has
a theoretic advantage of averting the need for thoracotomy
and supraceliac aortic crossclamping. This might result in
improved intraoperative hemodynamic stability, a reduction
in end-organ ischemia, and cardiopulmonary injury and
could therefore present an acceptable alternative to open sur-
gical intervention in high-risk patients.
Donas and colleagues9 identified 58 patients from 13 case
series from 1999–2006 whose prior surgical histories and
medical comorbidities had precluded open surgical repair
and were treated with the hybrid approach. The authors of
the study reported perioperative and midterm mortality rates
of 10.7% and 15.5% (median follow-up of 14.2 months),
respectively, with a reported graft patency of 97.8% (229/
234 grafts). This study, however, was disadvantaged in
that only 1 of the 13 case series included in the review/anal-
ysis had greater than 8 patients, and moreover, extensive
TAAAs (Crawford type II) were underrepresented in these
case series, comprising little over a third of the population
studied. Our review of more recent and larger series (5 of
which were not previously included) suggests that mortality
rates can vary between 6.7% and 24% (Table 3).12,17-21
Variability in mortality reflects the learning curve, extent
of the TAAA, and number of vessels targeted.
In all series of hybrid repair of TAAAs, anticipated rates
of permanent spinal cord infarction have not materialized,
despite extensive thoracoabdominal exclusion of aneurys-
mal aortas (type II and type III) in a majority of patients.
Furthermore, despite the retrograde approach to visceral
revascularization from iliac inflow vessels, the majority of
conduits remained patent without end-organ ischemia.
In our practice we now advocate routine revascularization
of the left subclavian artery before deploying endoluminal
stents, which necessitate the coverage of the left subclavian
origin. Recent reports from the European Collaborators on
Stent/Graft Techniques for Aortic Aneurysm Repair registry
support this policy, in which investigators have found that
spinal cord ischemia is increased in patients in whom pro-
phylactic revascularization of the subclavian artery is not un-
dertaken before thoracic stent deployment.22-24 Our practice
is not to perform routine CSF drainage in staged procedures
but to assess the patient immediately after endograft place-
ment. Confining CSF drainage to only those patients with
neurologic deficit minimizes the inadvertent risk of spinal
cord infection and bleeding associated with spinal catheter
placement.25 The only spinal cord ischemia in our series pre-
sented late, and in our opinion the risk/benefit ratio does noturgery c December 2009
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Authors
Institution, year of
publication No. Type II Type III Vessels*
Overall
mortality
Spinal
deficity
Graft
patency
Type 1þ3
leaks
Resch and coworkers17 Cleveland, 2005 13 38.5% 15.4% – 23.1% 30.7% (P ¼ 2/4) – 23.1%
Zhou and coworkers18 Houston, 2006 15 0 53.3% 40 (2.7) 6.7% 0 95% 0
Black and coworkers19 St Mary’s
London, 2006
26 62% 26.9% 94 (3.6) 23% 0 98% 26.9%
Bockler and cowoekres20 Heidelberg, 2007 11 18.2% 9.1% – – 0 – 9.1%
Chiesa and coworkers12 Milan 2007 13 15.4% 0 32 (2.5) 23.0% 7.7% (P ¼ 0/1) 100% 0
Lee and coworkers21 Gainesville, 2007 17 11.8% 47.0% 56 (3.3) 24.0% 0 96% 15.4%
Our study St George’s
London, 2008
18 44.4% 38.9% 54 (3.0) 16.7% 5.6% (P ¼ 1/1) 98.1% 11.8%
P, Permanent. Overall mortality indicates elective, urgent, and emergency procedures. *Average number of vessels revascularized per procedure from references. yEpisodes of
permanent neurologic deficit.A
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Dsubstantiate the use of prophylactic drainage, although we
acknowledge that the series is relatively small.
Staged aneurysm exclusion of the TAAA is our preferred
technique in the majority of patients undergoing elective pro-
cedures. No patients in this series died as a consequence of
aneurysm rupture before final endoluminal exclusion, al-
though this does remain a theoretic risk. The advantage of
adopting a staged approach to these patients is that it allows
for a shorter final endovascular procedure in hemodynami-
cally stable patients who have not had to endure an extensive
revascularization procedure and have not been subject to
hypothermia, renal ischemia, and blood loss. This facilitates
early extubation of the patient and immediate assessment of
spinal cord status. Deferring final aneurysm exclusion until
after visceral debranching also allows stent deployment to
take place in an angiography suite with full access to dynamic
computed tomography. The precise placement of the endolu-
minal stents in proximal thoracic aneurysms requires high-
quality dynamic angiography that is not always obtained
by using an image intensifier in the operating theater.
In the present series the incidence of type I endoleaks was
low. The largest previously reported series of 26 patients
observed that 1 in 5 patients had type I endoleaks, half of
which were not amenable to cure with further procedures.19
Despite the extensive stent coverage of the aorta, no type III
endoleaks were seen in our patients.
Accurate comparative analysis of patients undergoing tra-
ditional TAAA repair versus hybrid operations cannot be
made due to the disparity in both patient risk factors andThe Journal of Thoracic and Cthe learning curve with the hybrid technique. The present
study has demonstrated that successful outcome for patients
after hybrid repair of TAAAs is feasible in a cohort of elderly
patients historically deemed at high risk for traditional surgi-
cal repair. More than 80% of the patient cohort in the present
series had type II or type III TAAAs, and more than 60% had
a previous history of thoracotomy or aortic surgery. The me-
dian age of the patients was 73 years, the majority of whom
had a history of chronic obstructive lung disease, hyperten-
sion, and impaired cardiac function (Table 4).4-7 The level
of patient comorbidity appears to be greater than that seen
in the cohorts of patients reported in the large single-center
series of open TAAA repair. All patients had large aneurysms
(median diameter, 65 mm; range, 45–96 mm), which were at
risk of rupture and deemed to require intervention. Overall
patient perioperative mortality in our series was 16.7%,
which compares favorably to the outcomes reported in com-
munity series of all patients undergoing open repair and more
favorable than for elderly patients deemed at high risk of
open repair (30-day mortality of 50%).16 Furthermore, risks
of spinal paraplegia appear to be low despite the extensive
nature of the aneurysms treated and are in keeping with the
paraplegia rate reported by the European Collaborators on
Stent/Graft Techniques for Aortic Aneurysm Repair investi-
gators (5.6% vs 4%)22 and significantly lower than that seen
in patients undergoing traditional open type II repair (up to
25%).26 Cumulative incidence of perioperative complica-
tions was considerably high (44.4%, n ¼ 8/18), but this is
lower than the cited outcomes reported after open repair ofTABLE 4. Comparative patient risk factors for undergoing hybrid repair versus traditional TAAA repair
Authors Age (y)
Prior aortic
surgery (open/endo)
Crawford
type II–III COPD Cardiac status Hypertension
Coselli and coworkers4 66.1 25.3% thoracic 50.4% 36.9% 17.5% PTCA/CABG 75.8%
Safi and coworkers5 64.0 12.6% 25.2% 21.4% 28.2% coronary artery disease 73%
Cambria and coworkers6 70.5 28.8% 15.7% 56.7% – 87.2%
Estrera and coworkers7 67.0 – 34.5% 33.5% – 76.8%
Our study 73.0 61.1% 83.3% 66.7% 88.9% (SVS/ISCVS mild to severe) 88.9%
COPD, Chronic obstructive pulmonary disease; PTCA, percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass grafting; SVS/ISCVS, Society for Vascular
Surgery/North American Chapter of the International Society for Cardiovascular Surgery.ardiovascular Surgery c Volume 138, Number 6 1337
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DTAAAs.27,28 Late mortality, at 23 month’s median follow-
up, was 22.2% (n ¼ 4/18). The small cohort of patients
does not allow, at this point, a survival analysis, but the
short-term results are encouraging.
Recent technologic advances in stent graft design have re-
alized the possibility of deploying customized endografts
with fenestrations, allowing target vessel cannulation with
additional covered stents to afford antegrade perfusion of
the visceral vessels.29 Similarly, branched endovascular
grafts have also been successfully deployed, preserving
end-organ perfusion in selected patients, and some TAAAs
can now be treated with 4-vessel branched grafts.30 The need
for accurate measurements and precise manufacturing re-
sults in a lag time of several weeks in most, and anatomic
constraints with access and vessel tortuosity might not allow
all TAAAs to be treated with a total endovascular solution.
The emerging paradigm shift in the management of com-
plex TAAAs has increased the number of therapeutic op-
tions available for repair. In low-risk patients it would
appear that open repair in a high-volume center is the gold
standard. In higher-risk patients visceral hybrid revasculari-
zation or total endovascular solutions might be preferred. In
time, the number of visceral hybrid procedures is likely to
decrease as branched grafts become more prevalent, al-
though longer-term outcomes after hybrid repair are still
awaited. However, the hybrid option is likely to remain a vi-
able alternative to other modalities because not all TAAAs
will be treatable by using total endovascular solutions be-
cause of anatomic constraints, and open repair might not
be appropriate in high-risk patients.
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